John Bostjancic

John Bostjancic was appointed Chief Financial Officer following the merger. Mr. Bostjancic previously served as Chief Financial Officer of SeaSpine since 2015, and in 2022, Mr. Bostjancic was appointed to his expanded role at SeaSpine of Chief Operating and Financial Officer. Prior to this, he served as Treasurer and Senior Vice President at SeaSpine. Previously Mr. Bostjancic served as acting Chief Financial Officer of the SeaSpine business within Integra Life Sciences Holdings Corporation since 2014, and prior to that, he was Senior Vice President of Global Supply Chain at Integra from 2012 to 2014. His responsibilities included global planning, kitting, distribution, logistics, and customer service in the role, and he led the project team implementing the U.S. Food and Drug Administration’s “unique device identifier” rule in 2014. From 2008 until 2012, Mr. Bostjancic was Senior Vice President of Financial Planning and Analysis at Integra. Since joining Integra in 1999, he held roles of increasing responsibility in the finance organization, including corporate controller from 2003 through 2006. Before joining Integra, from 1998 through 1999, Mr. Bostjancic was a manager in the accounting standards team at Merck & Co., Inc., a publicly traded health care company. Prior to that, he worked in the business assurance organization at PricewaterhouseCoopers from 1993 through 1998. He received his B.S. in Accounting from the College of New Jersey.